Fate Therapeutics (FATE) has a market capitalization of $195.9M, based on 113.89M shares at a price of $1.72 (up 13.5% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $1.53 | 23,145,197 | 113,894,003 | $174,257,824.59 |
January 2025 | $1.30 | 44,294,904 | 113,894,003 | $148,062,203.90 |
December 2024 | $1.65 | 72,769,846 | 117,769,200 | $194,319,180.00 |
November 2024 | $3.17 | 80,121,109 | 117,769,200 | $373,328,364.00 |
October 2024 | $2.37 | 28,692,380 | 117,769,200 | $279,113,004.00 |
September 2024 | $3.50 | 20,289,329 | 117,769,200 | $412,192,200.00 |
August 2024 | $3.67 | 36,314,534 | 117,769,200 | $432,212,964.00 |
July 2024 | $5.33 | 45,547,528 | 117,769,200 | $627,709,836.00 |
June 2024 | $3.28 | 43,648,932 | 117,468,100 | $385,295,368.00 |
May 2024 | $3.68 | 57,016,328 | 117,468,100 | $432,282,608.00 |
April 2024 | $3.95 | 52,613,693 | 117,468,100 | $463,998,995.00 |
March 2024 | $7.34 | 55,384,140 | 101,104,300 | $742,105,562.00 |
February 2024 | $7.09 | 58,608,022 | 101,104,300 | $716,829,487.00 |
January 2024 | $6.16 | 66,013,010 | 101,104,300 | $622,802,488.00 |
December 2023 | $3.74 | 35,768,189 | 98,613,700 | $368,815,238.00 |
November 2023 | $2.49 | 41,391,690 | 98,613,700 | $245,548,113.00 |
October 2023 | $1.81 | 32,471,291 | 98,613,700 | $178,490,797.00 |
September 2023 | $2.12 | 66,788,408 | 98,568,000 | $208,964,160.00 |
August 2023 | $2.51 | 45,333,027 | 98,568,000 | $247,405,680.00 |
July 2023 | $4.13 | 31,858,656 | 98,568,000 | $407,085,840.00 |
June 2023 | $4.76 | 58,098,743 | 98,400,400 | $468,385,904.00 |
May 2023 | $5.05 | 50,551,311 | 98,400,400 | $496,922,020.00 |
April 2023 | $6.07 | 47,385,448 | 98,400,400 | $597,290,428.00 |
March 2023 | $5.70 | 70,958,001 | 98,054,700 | $558,911,790.00 |
February 2023 | $6.12 | 46,994,220 | 98,054,700 | $600,094,764.00 |
